Skip to content

Recording High Frequency Oscillations in Patients With Tumors and Epilepsy

Recording High Frequency Oscillations in Patients With Tumors and Epilepsy.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02320136
Acronym
HFO
Enrollment
120
Registered
2014-12-19
Start date
2014-06-30
Completion date
2025-12-31
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Tumor

Brief summary

The investigators want to characterize high-frequency oscillations (HFOs) in intracranial recordings, which may occur as markers of epileptogenic tissue and also under physiological stimulation. The investigators want to show that recording of high-frequency oscillations (HFOs) is feasible in our project population both intraoperatively and during presurgical physiological conditions.

Interventions

BEHAVIORALcognitive testing

patients perform simple tasks like watching a video or memorizing items

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients intend to be treated at the Klinik für Neurochirurgie * Patients fall into one of the patient groups: (1) Patients with symptomatic epilepsy with focal and/or secondary generalized seizures resistant to medication where a neurosurgical resection is considered as an intervention of epilepsy surgery. (2)Patients where a tumor is planned to be resected that has caused preoperative seizures. (3) Patients where a tumor is planned to be resected that has not caused preoperative seizures. * Male and Female subjects 18 years to 99 years of age * Written informed consent after participants' information

Exclusion criteria

* contraindications on ethical grounds * known or suspected non-compliance, drug or alcohol abuse, * enrolment into a clinical trial within last 4 weeks

Design outcomes

Primary

MeasureTime frame
HFO (high-frequency oscillations) occurrence1 week

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026